Evidence map›Paper›PMID 42845244›Full record

ArticleCirculation research2026

Endothelial Piezo1 Hyperactivity Drives Neurovascular Dysfunction in Hypertension.

Mohammad M Abd-Alhaseeb, Ahmed M Hashad, Hadi Esfandi, Curtis Plante, Xin Rui Lim, Reem M Aboushousha, Miguel Martin-Aragon Baudel, Manuel F Navedo, Benedek Erdos, Osama F Harraz

Abstract read
In one paragraph

Article in Circulation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mohammad M Abd-AlhaseebDepartment of Pharmacology, Larner College of Medicine, Vermont Center for Cardiovascular and Brain Health, University of Vermont, Burlington (M.M.A.-A., A.M.H., H.E., C.P., X.R.L., B.E., O.F.H.).ORCID 0000-0001-5388-5250
Ahmed M HashadDepartment of Pharmacology, Larner College of Medicine, Vermont Center for Cardiovascular and Brain Health, University of Vermont, Burlington (M.M.A.-A., A.M.H., H.E., C.P., X.R.L., B.E., O.F.H.).
Hadi EsfandiDepartment of Pharmacology, Larner College of Medicine, Vermont Center for Cardiovascular and Brain Health, University of Vermont, Burlington (M.M.A.-A., A.M.H., H.E., C.P., X.R.L., B.E., O.F.H.).
Curtis PlanteDepartment of Pharmacology, Larner College of Medicine, Vermont Center for Cardiovascular and Brain Health, University of Vermont, Burlington (M.M.A.-A., A.M.H., H.E., C.P., X.R.L., B.E., O.F.H.).ORCID 0009-0004-9550-4400
Xin Rui LimDepartment of Pharmacology, Larner College of Medicine, Vermont Center for Cardiovascular and Brain Health, University of Vermont, Burlington (M.M.A.-A., A.M.H., H.E., C.P., X.R.L., B.E., O.F.H.).ORCID 0000-0002-4166-0377
Reem M AboushoushaDepartment of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington (R.M.A.).ORCID 0000-0003-2284-2180
Miguel Martin-Aragon BaudelORCID 0000-0001-9399-4013
Manuel F NavedoDepartment of Pharmacology, University of California Davis (M.M.-A.B., M.F.N.).ORCID 0000-0001-6864-6594
Benedek ErdosDepartment of Pharmacology, Larner College of Medicine, Vermont Center for Cardiovascular and Brain Health, University of Vermont, Burlington (M.M.A.-A., A.M.H., H.E., C.P., X.R.L., B.E., O.F.H.).ORCID 0000-0002-9074-2491
Osama F HarrazDepartment of Pharmacology, Larner College of Medicine, Vermont Center for Cardiovascular and Brain Health, University of Vermont, Burlington (M.M.A.-A., A.M.H., H.E., C.P., X.R.L., B.E., O.F.H.).ORCID 0000-0003-2061-1100

Funding

Vermont Center for Cardiovascular and Brain HealthP20GM135007 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI Diego Adrianzen Herrera · 2020 to 2026
$17.4M
Endothelial Piezo1 channel and cerebral blood flow controlR01HL169681 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI Osama F Harraz · 2023 to 2026
$2.3M
Brain capillary Piezo1 ion channels and blood flow regulation in Alzheimer’s DiseaseR21AG082193 · NIA · UNIVERSITY OF MIAMI CORAL GABLES · PI BRACKO, OLIVER, HARRAZ, OSAMA F · 2023 to 2024
$434k
American Heart Association-American Stroke Association 20CDA35310097 - OSAMA HARRAZNHLBI NIH HHS R01 HL169681NIA NIH HHS R21 AG082193NIGMS NIH HHS P20 GM135007
6 · The paper itself

Abstract

backgroundHypertension is a major driver of neurovascular dysfunction and cognitive decline, yet the molecular mechanisms linking elevated arterial pressure to impaired cerebral blood flow remain poorly defined. Piezo1, a mechanosensitive cation channel enriched in the brain endothelium, is a candidate mediator of cerebral blood flow deficits during hypertension.

methodsUsing 2 distinct mouse models of hypertension-BPH/2J mice (genetically hypertensive strain) and angiotensin II-infused C57BL/6J mice-we assessed brain endothelial Piezo1 activity using patch-clamp electrophysiology. Endothelial-specific Piezo1 deletion models were used to evaluate the role of the channel in hypertension-associated cerebrovascular impairment. Cerebral blood flow responses were measured in vivo by laser speckle contrast imaging, and super-resolution nanoscopy was used to quantify Piezo1 nanoscale organization. Behavioral testing was used to assess cognition.

resultsGenetic manipulation of endothelial Piezo1 had minimal impact on baseline blood pressure. However, cerebral endothelial Piezo1 activity was markedly elevated in different hypertension models. Deletion of endothelial Piezo1 protected against hypertension-induced cerebrovascular deficits, including impaired vasomotion, reduced functional hyperemia, and blunted CO

conclusionsHypertension increased the gain of Piezo1 function in brain endothelial cells, promoting dysfunctional neurovascular signaling and cognitive impairment. Targeting Piezo1 or PKC signaling selectively restored cerebrovascular regulation. This work identifies a mechanosensitive pathway that could be leveraged to protect the hypertensive brain.

Indexed as

cognitionendothelial cellshypertensionneurovascular couplingprotein kinase C

Identifiers

PMID42845244
PMCPMC13651590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.